J Bacteriol. 1991 October; 173(19): 6242-6248
The Escherichia coli ts8 mutation is an allele of fda, the gene encoding fructose-1,6-diphosphate aldolase.
M Singer,
P Rossmiessl,
B M Cali,
H Liebke and
C A Gross
Department of Bacteriology, University of Wisconsin-Madison 53706.
ABSTRACT
The ts8 mutant of Escherichia coli has previously been shown to preferentially inhibit stable RNA synthesis when shifted to the nonpermissive temperature. We demonstrate in this report that the ts8 mutation is an allele of fda, the gene that encodes the glycolytic enzyme fructose-1,6-diphosphate aldolase. We show that ts8 and a second fda mutation, h8, isolated and characterized by A. Böck and F. C. Neidhardt, are dominant mutations and that they encode a thermolabile aldolase activity.
J Bacteriol. 1991 October; 173(19): 6242-6248
This article has been cited by other articles:
-
Schneider, D. A., Gourse, R. L.
(2003). Changes in the Concentrations of Guanosine 5'-Diphosphate 3'-Diphosphate and the Initiating Nucleoside Triphosphate Account for Inhibition of rRNA Transcription in Fructose-1,6-Diphosphate Aldolase (fda) Mutants. J. Bacteriol.
185: 6192-6194
[Abstract]
[Full Text]
-
Morita, T., El-Kazzaz, W., Tanaka, Y., Inada, T., Aiba, H.
(2003). Accumulation of Glucose 6-Phosphate or Fructose 6-Phosphate Is Responsible for Destabilization of Glucose Transporter mRNA in Escherichia coli. J. Biol. Chem.
278: 15608-15614
[Abstract]
[Full Text]
Copyright © 1991 by the American Society for Microbiology. All rights reserved.